Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PluroGel PN for Mildly Infected Diabetic Foot Ulcer
NCT02119754Phase 2Completed
- Sponsor
- PluroGen Therapeutics, LLC
- Start
- Oct 2013
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in diabetic foot ulcer (DFU), sponsored by PluroGen Therapeutics, LLC. Primary endpoint: Clinical Response at 14 days. Started Oct 2013; status: completed.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02119754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119754.